Covered recipient · General Payments record
ABDUL RAFEH NAQASH
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$19,956.69
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $10,281.98 | 4 |
| Consulting Fee | $1,098.58 | 1 |
| Food and Beverage | $458.24 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $11,539.55 | 6 |
| PFIZER INC. | $135.00 | 1 |
| Acerta Pharma LLC | $128.78 | 1 |
| GENZYME CORPORATION | $35.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $128.78 | 09/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105868313 | CMS |
| GENZYME CORPORATION | $35.47 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139887196 | CMS |
| JAZZ PHARMACEUTICALS INC. | $158.99 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150219353 | CMS |
| JAZZ PHARMACEUTICALS INC. | $175.99 | 04/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1150219355 | CMS |
| JAZZ PHARMACEUTICALS INC. | $40.00 | 04/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1150219357 | CMS |
| JAZZ PHARMACEUTICALS INC. | $8,534.95 | 04/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1150219359 | CMS |
| JAZZ PHARMACEUTICALS INC. | $1,098.58 | 04/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150219361 | CMS |
| JAZZ PHARMACEUTICALS INC. | $1,531.04 | 04/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1150219363 | CMS |
| PFIZER INC. | $135.00 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131331821 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.